Living

US FDA approves GSK's oral antibiotic for drug-resistant UTIs

By Reuters Reuters
A staff member walks down stairs in the main lobby of GSK offices in London, Britain, February 20, 2025. REUTERS/Chris J. Ratcliffe
A staff member walks down stairs in the main lobby of GSK offices in London, Britain, February 20, 2025. REUTERS/Chris J. Ratcliffe Chris J Ratcliffe Reuters

The U.S. FDA has approved GSK's oral antibiotic to treat complicated urinary tract infections, the regulator said on Wednesday, giving patients a new treatment option against drug-resistant infections.

(Reporting by Sriparna Roy in Bengaluru and Bhanvi Satija in London; Editing by Tasim Zahid)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published June 17, 2026 at 11:11 AM.

Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER